Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Lux Research Announces First Quarter Update of Lux Nanotech Index™

Lux Research Announces First Quarter Update of Lux Nanotech Index™

Lux Research

New York, NY | Posted on April 03, 2006

Lux Research, the world’s leading nanotechnology research and advisory firm, today announced its quarterly update to the Lux Nanotech Index™. The Index serves as a benchmark for the value that markets ascribe to emerging nanotechnology and forms the basis of the $93 million PowerShares Lux Nanotech Portfolio (AMEX:PXN), the first nanotechnology exchange-traded fund (ETF).

The components of the Lux Nanotech Index™ are split into two groups: 1) nanotech specialists – small and mid-sized companies that focus specifically on developing or funding emerging nanotechnology applications, and 2) end-use incumbents – large companies that are applying nanotechnology to existing product lines. Nanotech specialists account for 75% of the modified equal-dollar-weighted index; end-use incumbents account for 25%.

This update replaces Westaim with NUCRYST Pharmaceuticals among the nanotech specialists. NUCRYST, which develops therapeutic applications of silver nanoparticles, was a business unit of Westaim before it was spun off in a late December 2005 IPO; with the spinoff, Westaim’s nanotech commercialization activities have been divested. “The Acticoat antimicrobial bandages that NUCRYST developed with partner Smith & Nephew form a great example of how nanotechnology is changing products and shifting market shares today,” said Lux Research President and Director of Research Matthew M. Nordan.

The PowerShares Lux Nanotech Portfolio, which is based on the Index, is up 19.90% since its introduction in October 2005 and now has more than $93 million in assets under management. The Lux Nanotech Index™ is intended to be representative, and is not specifically designed to outperform the Nasdaq or other indices.

The components of the Lux Nanotech Index™ are:

Nanotech specialists

  • Accelrys (ACCL)
  • Altair Nanotechnologies (ALTI)
  • American Pharmaceutical Partners (APPX)
  • Arrowhead Research (ARWR)
  • Biosante Pharmaceuticals (BPA)
  • Elan (ELN)
  • FEI Company (FEIC)
  • Flamel Technologies (FLML)
  • Headwaters (HW)
  • Immunicon (IMMC)
  • Nanophase Technologies (NANX)
  • NUCRYST Pharmaceuticals (NCST)
  • NVE Corporation (NVEC)
  • Cambridge Display Technology (OLED)
  • Symyx Technologies (SMMX)
  • Harris & Harris Group (TINY)
  • Veeco Instruments (VECO)

End-use incumbents

  • Air Products & Chemicals (APD)
  • BASF (BF)
  • E.I. Du Pont de Nemours & Company (DD)
  • General Electric (GE)
  • Hewlett-Packard (HPQ)
  • Intel (INTC)
  • International Business Machines (IBM)
  • 3M (MMM)
  • Toyota (TM)

Full details on the Lux Nanotech Index™ are available at www.luxresearchinc.com/luxni.html.

####

About Lux Research:
Lux Research is the world’s leading nanotechnology research and advisory firm. We help our clients make better decisions to profit from nanoscale science and technology, tapping into our analysts’ unique expertise and unrivaled network. Our clients include top decision makers at large corporations, portfolio managers and analysts at leading financial institutions, CEOs of the most innovative start-ups, and visionary public policy makers.

For more information, please click here.

Contact:
Lux Research Inc.
Peter Hebert
646-723-0702
peter.hebert@luxresearchinc.com

Copyright © Lux Research

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Arrowhead Issues Open Letter to Shareholders October 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Announcements

Nano Ruffles in Brain Matter: Freiburg researchers decipher the role of nanostructures around brain cells in central nervous system function October 31st, 2014

Gold nanoparticle chains confine light to the nanoscale October 31st, 2014

'Nanomotor lithography' answers call for affordable, simpler device manufacturing October 31st, 2014

Device invented at Johns Hopkins provides up-close look at cancer on the move: Microscopic view of metastasis could give insight about how to keep cancer in check October 31st, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE